Top 4 Health Care Stocks That May Keep You Up At Night This Month
Top 4 Health Care Stocks That May Keep You Up At Night This Month
As of June 11, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年6月11日，在醫療保健板塊中有四隻股票可能向將動量視爲交易決策中的關鍵標準的投資者發出真正的警告信號。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI是一種動量指標，它將股票在股價上升的日子裏的強度與在股價下跌的日子裏的強度進行比較。與股票價格的走勢相比，它可以讓交易員更好地了解股票在短期內的表現。當RSI高於70時，資產通常被認爲是超買的，據Benzinga Pro稱。
Here's the latest list of major overbought players in this sector.
以下是行業中超買的主要股票列表。
Applied Therapeutics Inc (NASDAQ:APLT)
Applied Therapeutics股份有限公司（納斯達克股票代碼：APLT）
- On May 9, Applied Therapeutics posted downbeat quarterly results. "Preparations are underway for the potential approval and commercial launch of govorestat for the treatment of Classic Galactosemia in the US and EU, following the significant regulatory progress we have already made in 2024," said Shoshana Shendelman, PhD, Founder and CEO of Applied Therapeutics. The company's stock gained around 19% over the past five days and has a 52-week high of $9.39.
- RSI Value: 70.41
- APLT Price Action: Shares of Applied Therapeutics gained 9.4% to close at $5.11 on Monday.
- 5月9日，Applied Therapeutics公佈了不樂觀的季度業績報告。該公司創始人兼首席執行官Shoshana Shendelman博士表示：“在2024年我們已經取得了重要的監管進展後，陸續爲美國和歐盟對經典半乳糖血症進行治療的govorestat進行潛在批准和商業推廣做準備。”該公司的股票在過去五天上漲了約19%，52周最高價爲9.39美元。
- RSI值：70.41
- APLT股價表現：週一，Applied Therapeutics的股票上漲9.4％，收於5.11美元。
Eli Lilly And Co (NYSE:LLY)
Eli Lilly And Co（NYSE: LLY）
- On June 8, Eli Lilly shared detailed results from the SYNERGY-NASH phase 2 study. The company's stock gained around 14% over the past month and has a 52-week high of $871.63.
- RSI Value: 82.09
- LLY Price Action: Shares of Eli Lilly rose 1.8% to close at $865.00 on Monday.
- 6月8日，Eli Lilly公司公佈了來自SYNERGY-NASH第二階段研究的詳細結果。該公司的股票在過去一個月中上漲了約14％，52周最高價爲871.63美元。
- RSI值：82.09
- LLY股價表現：週一，Eli Lilly的股票上漲1.8％，收於865.00美元。
Insmed Inc (NASDAQ:INSM)
Insmed股份有限公司（納斯達克股票代碼：INSM）
- On May 30, Insmed announced the pricing of a $650 million public offering. The company's stock gained around 132% over the past month and has a 52-week high of $60.74.
- RSI Value: 84.14
- INSM Price Action: Shares of Insmed gained 5.4% to close at $59.90 on Monday.
- 5月30日，Insmed宣佈定價6.5億美元的公開發行。該公司的股票在過去一個月中上漲了約132％，52周最高價爲60.74美元。
- RSI值：84.14
- INSM股價表現：週一，Insmed的股票上漲5.4％，收於59.90美元。
TransMedics Group Inc (NASDAQ:TMDX)
TransMedics集團股份有限公司（納斯達克股票代碼：TMDX）
- On April 30, TransMedics posted upbeat quarterly results and raised its 2024 guidance. "We are pleased with our first quarter results as we simultaneously drove continued revenue growth, expanded our infrastructure, and achieved profitability," said Waleed Hassanein, MD, President and Chief Executive Officer. The company's stock jumped around 9% over the past five days and has a 52-week high is $145.92.
- RSI Value: 71.12
- TMDX Price Action: Shares of TransMedics Group gained 5.5% to close at $144.67 on Monday.
- 4月30日，TransMedics公佈了樂觀的季度業績報告，並提高了2024年的業績預期。首席執行官Waleed Hassanein博士表示：“我們對第一季度的業績結果感到滿意，同時推動了持續的收入增長，擴大了我們的基礎設施，並實現了盈利。”該公司的股票在過去五天上漲了約9％，52周最高價爲145.92美元。
- RSI值：71.12
- TMDX股價表現：週一，TransMedics Group的股票上漲5.5％，收於144.67美元。
Read More: Jim Cramer Isn't Recommending SLB, And BlackBerry? 'Nothing There'
閱讀更多：Jim Cramer不推薦SLB，而黑莓呢？ '沒有什麼可信賴的'
譯文內容由第三人軟體翻譯。